Amir Ben Tov

Dr. Amir Ben Tov

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MLMatan Levine-Tiefenbrun
Matan Levine-Tiefenbrun
IYIdan Yelin
Idan Yelin
RKRachel Katz
Rachel Katz
EHEsma Herzel
Esma Herzel
ZGZiv Golan
Ziv Golan
RKRoy Kishony
Roy Kishony

4 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
BMBarak Mizrahi
Barak Mizrahi
RLRoni Lotan
Roni Lotan
NKNir Kalkstein
Nir Kalkstein
APAsaf Peretz
Asaf Peretz
GPGalit Perez
Galit Perez
TPTal Patalon
Tal Patalon
The short-term effectiveness of a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was widely demonstrated. However, long term effectiveness is still unknown. Leveraging the centralized computerized database of Maccabi Healthcare Services (MHS), we assessed the correlation between time-from-vaccine and incidence of breakthrough infection between June 1 and July 27, the date of analysis. After controlling for potential confounders as age and comorbidities, we found a significant 1.51 fold (95% CI, 1.38–1.66) increased risk for infection for early vaccinees compared to those vaccinated later that was similar across all ages groups. The increased risk reached 2.26- fold (95% CI, 1.80–3.01) when comparing those who were vaccinated in January to those vaccinated in April. This preliminary finding of vaccine waning as a factor of time from vaccince should prompt further investigations into long-term protection against different strains.

10 June 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
OMOren Milman
Oren Milman
IYIdan Yelin
Idan Yelin
NANoga Aharony
Noga Aharony
RKRachel Katz
Rachel Katz
EHEsma Herzel
Esma Herzel
RKRoy Kishony
Roy Kishony

1 August 2013 in Pediatric Emergency Care
Verified
Journal Article
Closed access
IAItay Ayalon
Itay Ayalon
MGMiguel Marcelo Glatstein
Miguel Marcelo Glatstein
GZGalit Zaidenberg-Israeli
Galit Zaidenberg-Israeli
DSDennis Scolnik
Dennis Scolnik
ATAmir Ben Tov
Amir Ben Tov
SRShimon Reif
Shimon Reif
Community-acquired pneumonia (CAP) is an important cause of acute respiratory disease in ambulatory care settings. The objective of this study was to assess the accuracy of medical history and physical examination in diagnosing CAP. Pediatric residents prospectively completed a questionnaire documenting patients' medical history and physical examination whenever a chest radiograph was ordered on patients 1 month to 16 years of age. Chest radiographs were read by a pediatric radiologist. Of 525 children participating in the study, 181 (34%) demonstrated findings of pneumonia. Thirty-four (19%) had no symptoms other than fever, and 51 (28%) had normal lung auscultation. Pediatric residents had the same interpretation in 85% of cases in which radiographic CAP was diagnosed by the radiologist, and in 76% of cases in which radiographic pneumonia was excluded by the radiologist. Results demonstrate the significant added value of chest radiography as an ancillary test for diagnosis of pneumonia in the emergency department setting.

18 February 2014 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
ANAdi Nosrati
Adi Nosrati
ATAmir Ben Tov
Amir Ben Tov
SRShimon Reif
Shimon Reif

7 February 2018 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
AYAnat Yerushalmy-Feler
Anat Yerushalmy-Feler
RTRiva Tauman
Riva Tauman
ADAri DeRowe
Ari DeRowe
EAEran Averbuch
Eran Averbuch
ATAmir Ben Tov
Amir Ben Tov
SCShlomi Cohen
Shlomi Cohen
Enlarged tonsils and adenoids are the major etiology of obstructive sleep apnea (OSA) in children. Lymphatic hyperplasia is common to both OSA and celiac disease. We aimed to investigate the effect of a gluten-free diet on OSA symptoms in children with celiac disease. Children with celiac disease aged 2–18 years were prospectively recruited before the initiation of a gluten-free diet. Children with negative celiac serology who underwent gastrointestinal endoscopies for other indications served as controls. All participants completed a validated OSA-related symptoms questionnaire and the pediatric sleep questionnaire (PSQ) at baseline and 6 months later. Thirty-four children with celiac disease (mean age 6.6 ± 3.5 years) and 24 controls (mean age 7.3 ± 4.6 years, P = 0.5) were recruited. There were no significant differences in gender, body mass index or season at recruitment between the two groups. The rate of positive PSQ scores was higher (more OSA-related symptoms) in the control group compared to the celiac group, both at recruitment and at the 6-month follow-up (33.3% vs. 11.8%, P = 0.046, and 16.7% vs. 0, P = 0.014, respectively). PSQ scores improved significantly in both groups at the 6-month follow-up (P < 0.001 for both). Improvement was significantly higher in the celiac group compared to controls (0.1 ± 0.09 vs.0.06 ± 0.06, respectively, P = 0.04). Children with celiac disease had fewer OSA-related symptoms than controls, but the degree of improvement following the initiation of a gluten-free diet was significantly higher. These findings suggest that a gluten-free diet may improve OSA-related symptoms in children with celiac disease.